$AKTX The latest on the coronavirus pandemic
By Joshua Berlinger, Steve George, Ivana Kottasová, Ed Upright, Melissa Macaya, Meg Wagner and Mike Hayes, CNN
Updated 2:12 p.m. ET, July 21, 2020
https://edition.cnn.com/world/live-news/coronavirus-pandemic-07-21-20-intl/h_d8ed32faec73327b10cf05a90928fc91
The number of people who have had Covid-19 was much greater than the official case count, according to data and a new analysis released by the US Centers for Disease Control and Prevention. But the country is far from a level that would give the population herd immunity.
Depending on the region, the number of people infected was sometimes six to 24 times the number of reported cases, the CDC team said.
“For most sites, it is likely that greater than 10 times more SARS-CoV-2 infections occurred than the number of reported COVID-19 cases,” the team concluded.
These numbers are likely conservative, according to the study published Tuesday in the Journal of the American Medical Association. The data used in the analysis was published on the CDC website Tuesday.
CDC Director Dr. Robert Redfield said earlier this month that testing had likely missed 90% or so of cases.
The CDC wanted to see if the official test tally showed the actual numbers of infections. They analyzed test results from 16,000 people in 10 geographically diverse cities and states done between March and early May. These people were tested, not because they had coronavirus symptoms but for other reasons – for instance, if they were having surgery and the hospital did the test as a matter of course.
These tests would give a broader sense of who has been infected by the novel coronavirus than just the number of people who have sought tests because they didn’t feel well and suspected they had Covid-19.
There is a limit to this methodology. These people tested may not have been representative of the general population, nor does it take into account the disease exposure risk. It’s also possible that there could be some overlap, and people may have been tested more than once, the CDC said. The infections may not be evenly distributed even in these regions.
The results do show that the majority of people in these 10 sites have not had Covid-19. It also shows that people who are asymptomatic are still contributing to the spread of the disease, so the authors argue that the public should continue to take steps to prevent the spread by wearing masks, staying physically distant and staying home as much as possible.
By Joshua Berlinger, Steve George, Ivana Kottasová, Ed Upright, Melissa Macaya, Meg Wagner and Mike Hayes, CNN
Updated 2:12 p.m. ET, July 21, 2020
https://edition.cnn.com/world/live-news/coronavirus-pandemic-07-21-20-intl/h_d8ed32faec73327b10cf05a90928fc91
The number of people who have had Covid-19 was much greater than the official case count, according to data and a new analysis released by the US Centers for Disease Control and Prevention. But the country is far from a level that would give the population herd immunity.
Depending on the region, the number of people infected was sometimes six to 24 times the number of reported cases, the CDC team said.
“For most sites, it is likely that greater than 10 times more SARS-CoV-2 infections occurred than the number of reported COVID-19 cases,” the team concluded.
These numbers are likely conservative, according to the study published Tuesday in the Journal of the American Medical Association. The data used in the analysis was published on the CDC website Tuesday.
CDC Director Dr. Robert Redfield said earlier this month that testing had likely missed 90% or so of cases.
The CDC wanted to see if the official test tally showed the actual numbers of infections. They analyzed test results from 16,000 people in 10 geographically diverse cities and states done between March and early May. These people were tested, not because they had coronavirus symptoms but for other reasons – for instance, if they were having surgery and the hospital did the test as a matter of course.
These tests would give a broader sense of who has been infected by the novel coronavirus than just the number of people who have sought tests because they didn’t feel well and suspected they had Covid-19.
There is a limit to this methodology. These people tested may not have been representative of the general population, nor does it take into account the disease exposure risk. It’s also possible that there could be some overlap, and people may have been tested more than once, the CDC said. The infections may not be evenly distributed even in these regions.
The results do show that the majority of people in these 10 sites have not had Covid-19. It also shows that people who are asymptomatic are still contributing to the spread of the disease, so the authors argue that the public should continue to take steps to prevent the spread by wearing masks, staying physically distant and staying home as much as possible.
Recent AKTX News
- Akari Therapeutics Discusses Breakthrough Potential of AKTX-101 and Novel Spliceosome-Modulating ADC Platform in Virtual Investor “What This Means” Segment Following ASCO Abstract Acceptance • GlobeNewswire Inc. • 05/28/2026 01:17:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2026 08:40:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 08:30:23 PM
- This Emerging Biotech Wave Could Create the Next Monster Healthcare Winners • GlobeNewswire Inc. • 05/22/2026 01:42:40 PM
- Akari Therapeutics Reports Breakthrough Preclinical Data Demonstrating Synergistic Activity of AKTX-101 with KRAS Inhibition in KRAS-Mutated Pancreatic Cancer Models • GlobeNewswire Inc. • 05/21/2026 09:01:00 PM
- Akari Therapeutics Announces $5.5 Million Private Placement Offering • GlobeNewswire Inc. • 05/21/2026 12:30:00 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 05/21/2026 12:15:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/19/2026 09:00:50 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/18/2026 09:15:18 PM
- Akari Therapeutics to Present at A.G.P.’s Annual Healthcare Company Showcase • GlobeNewswire Inc. • 05/18/2026 01:05:00 PM
- Akari Therapeutics Secures Key European Patent For Its Novel RNA Splicing Modulator ADC Payload, Strengthening Global IP Estate For All Major Global Markets • GlobeNewswire Inc. • 05/12/2026 12:33:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 05/08/2026 09:08:03 PM
- Akari Therapeutics Secures Australian Patent Approval, Further Expanding Global Protection of Its Proprietary PH1 RNA Splicing Modulator ADC Payload • GlobeNewswire Inc. • 04/27/2026 12:35:00 PM
- Akari Therapeutics ASCO Abstract Acceptance Highlights Potential for AKTX-101 ADC to Treat KRAS Mutant Tumors • GlobeNewswire Inc. • 04/21/2026 01:00:00 PM
- Akari Therapeutics Reports Positive Preclinical Data for AKTX-101 Demonstrating Differentiated Cytotoxicity for First-in-Class TROP2 ADC Payload Targeting RNA Splicing • GlobeNewswire Inc. • 04/20/2026 12:35:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/16/2026 04:15:07 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/10/2026 08:15:02 PM
- Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing Strategic Partnership with WuXi XDC • GlobeNewswire Inc. • 04/09/2026 12:50:00 PM
- Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing • GlobeNewswire Inc. • 04/06/2026 12:45:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:39:37 PM
- Akari Therapeutics to present ADC research at AACR Annual Meeting 2026 • IH Market News • 03/18/2026 03:02:39 PM
- Akari Therapeutics Announces Abstract Accepted for Poster Presentation at the American Association for Cancer Research Annual Meeting 2026 • GlobeNewswire Inc. • 03/18/2026 12:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/17/2026 09:07:26 PM
- Akari Therapeutics Announces ADS Ratio Change • GlobeNewswire Inc. • 03/17/2026 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 09:00:03 PM
